IFRX
Price
$0.79
Change
-$0.02 (-2.47%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
54.73M
31 days until earnings call
LXEO
Price
$4.02
Change
-$0.10 (-2.43%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
136.75M
49 days until earnings call
Interact to see
Advertisement

IFRX vs LXEO

Header iconIFRX vs LXEO Comparison
Open Charts IFRX vs LXEOBanner chart's image
InflaRx
Price$0.79
Change-$0.02 (-2.47%)
Volume$779
Capitalization54.73M
Lexeo Therapeutics
Price$4.02
Change-$0.10 (-2.43%)
Volume$14.04K
Capitalization136.75M
IFRX vs LXEO Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. LXEO commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Hold and LXEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (IFRX: $0.81 vs. LXEO: $4.12)
Brand notoriety: IFRX and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 28% vs. LXEO: 117%
Market capitalization -- IFRX: $54.73M vs. LXEO: $136.75M
IFRX [@Biotechnology] is valued at $54.73M. LXEO’s [@Biotechnology] market capitalization is $136.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, LXEO is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 5 TA indicator(s) are bullish while LXEO’s TA Score has 6 bullish TA indicator(s).

  • IFRX’s TA Score: 5 bullish, 4 bearish.
  • LXEO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than IFRX.

Price Growth

IFRX (@Biotechnology) experienced а +1.58% price change this week, while LXEO (@Biotechnology) price change was +5.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

IFRX is expected to report earnings on Jul 31, 2025.

LXEO is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXEO($137M) has a higher market cap than IFRX($54.7M). LXEO YTD gains are higher at: -37.386 vs. IFRX (-67.296). IFRX has higher annual earnings (EBITDA): -44.22M vs. LXEO (-107.14M). LXEO has more cash in the bank: 99.8M vs. IFRX (65.9M). IFRX has less debt than LXEO: IFRX (703K) vs LXEO (9.4M). IFRX has higher revenues than LXEO: IFRX (130K) vs LXEO (0).
IFRXLXEOIFRX / LXEO
Capitalization54.7M137M40%
EBITDA-44.22M-107.14M41%
Gain YTD-67.296-37.386180%
P/E RatioN/AN/A-
Revenue130K0-
Total Cash65.9M99.8M66%
Total Debt703K9.4M7%
FUNDAMENTALS RATINGS
IFRX: Fundamental Ratings
IFRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IFRXLXEO
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDEIY10.790.11
+1.03%
Redeia Corporacion SA
HINOF2.54N/A
N/A
Hino Motors Ltd.
JWCTF0.25N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
CNLTN32.50N/A
N/A
Connecticut Light & Power Co. (The)
CRZY30.12N/A
N/A
Crazy Woman Creek Bancorp Inc.

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and LXEO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and LXEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
-2.98%
LXEO - IFRX
29%
Poorly correlated
-1.44%
RCUS - IFRX
28%
Poorly correlated
-6.47%
VERA - IFRX
28%
Poorly correlated
-2.75%
NMRA - IFRX
26%
Poorly correlated
-5.32%
ARWR - IFRX
26%
Poorly correlated
+0.06%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.44%
ARWR - LXEO
48%
Loosely correlated
+0.06%
COGT - LXEO
46%
Loosely correlated
-3.14%
BEAM - LXEO
43%
Loosely correlated
-1.98%
KOD - LXEO
43%
Loosely correlated
-2.38%
RGNX - LXEO
41%
Loosely correlated
-4.11%
More